While genetic testing rates for advanced ovarian cancer have increased, gaps in physician understanding and confidence in interpreting results may limit optimal biomarker-driven treatment and patient ...
Ms Christian revealed that Manx Care has consistently missed the 62-day referral-to-treatment standard, which requires 85 percent of patients to begin treatment within 62 days of a suspected cancer ...